Clinical trials
Phase 2/3 Insulin Resistance trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 3 |
| Emory University | 2 |
| Brigham and Women's Hospital | 1 |
| Parke-Davis | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Steven J. Russell, MD, PhD | 1 |
| The University of Texas Medical Branch, Galveston | 1 |
| University of Colorado, Denver | 1 |
| University of Missouri-Columbia | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 15 |
| Diabetes Mellitus, Type 1 | 4 |
| Atherosclerosis | 2 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Arterial Occlusive Diseases | 1 |
| Burns | 1 |
| Cross Infection | 1 |
| Hyperglycemia | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.